| Population at Risk | |
- Recognize that the natural history of diabetes includes an asymptomatic phase that would be detected only through screening or opportunistic testing and that complications can occur before clinical symptoms of diabetes are apparent.
 - Recognize that the prevalence of diabetes increases significantly with age.
- Know that the risk of type 2 diabetes is significantly increased among patients with a first-degree family member with a history of diabetes.
- Know that nearly all minority groups in the U.S. have an increased risk of type 2 diabetes.
- Recognize that women with gestational diabetes have a high risk of developing type 2 diabetes, with the highest incidence in the first 5 years after pregnancy.
- Recognize that women with polycystic ovarian syndrome have a higher prevalence of type 2 diabetes than women without the syndrome.
- Note that the risk of diabetes significantly increases with increasing obesity, with the greatest risk in persons with abdominal fat accumulation.
- Note that persons with CVD, hypertension, dyslipidemia, and other features of the metabolic syndrome have an increased incidence of diabetes and that some medications place patients at risk for both metabolic syndrome and diabetes.
- Note that diabetes increases the risk of cardiovascular events, and that men over age 55 and women over age 60 with diabetes have at least a 10% risk of cardiovascular events over 10 years.
|  | | FAQs |
|
|
Denice S. Feig, MD, MSc, FRCPC has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Lorraine Lipscombe, MD, FRCPC has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Sonal Singh, MD, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Deborah Korenstein, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Richard B. Lynn, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. |
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted © 2012 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
Screening for Type 2 Diabetes
